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Background & aims: Preterm infants are a heterogeneous group and many accumulate growth deﬁcits
before and after initial hospital discharge. Although this is associated with worse cognitive outcome,
recent meta-analyses suggest that nutrient fortiﬁcation of breast milk, or the use of nutrient and energy
rich formulae after discharge exert little effect on growth and neurodevelopment. However, the
complexity of study design, inclusion criteria and outcome parameters, combined with differences in
formula composition mean that meta-analysis may overlook important effects of differing interventions
in sub-groups.
Methods: We systematically identiﬁed evidence and mapped the information on Participants, Inter-
vention, Comparator, and Outcome (PICO) from 31 published studies illustrating the marked heteroge-
neity in study design and interventions next to outcomes on (quality of) growth and neurodevelopment.
Results: Despite signiﬁcant heterogeneity in study design, we found that nutrient enriched diets after
discharge show no negative effects but frequently improve growth parameters at some point in the
course of the study, in particular for boys. The data indicates that when energy requirements are
adequate, increased protein results in increased growth and lean mass (LM) accretion; In particular,
higher protein to energy ratios lead to increased lean mass accretion, and increased head circumference
(HC) at one year. However, improvements in neurodevelopmental outcome were rarely seen.
Conclusion: This comprehensive evidence mapping approach to the ﬁeld provides a broad but detailed
overview of the currently available evidence. Furthermore, we identiﬁed key gaps in existing knowledge
on the role of nutrient enrichment in the post-discharge period.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).ent plethysmography; AGA,
edance analysis; BPD, bron-
ohydrates; -e, protein and/or
tational age; GMDS, Grifﬁth
ssamanick, and Sherrards'
fat free mass; MAC, mid-arm
t scale; P:E ratio, protein:e-
ym), participant e interven-
preferred reporting items for
formula; SFT, skinfold thick-
rm formula.
31 (0)631 904 735; fax: þ31
Teller), nicholas.embleton@
s.edu (I.J. Grifﬁn), ruurd.
Nutrition, The Netherlands.
Ltd. This is an open access article u1. Introduction
During their initial hospital stay many preterm infants accu-
mulate signiﬁcant nutrient deﬁcits that result in growth restriction
[28]. This malnutrition coincides with a period of functional organ
development and intense brain growth that may, in part, explain
why preterm infants have higher risks for cognitive impairment and
low IQ scores in later life. In addition, preterm infants seem to be at
higher risk for subsequent development of themetabolic syndrome,
including insulin insensitivity, hypertension, and cardiovascular
disease,whichmaybe due to sub-optimal nutrition at sensitive time
points in early life [42]. Whether the causation for the long-term
risk factors relates to the abbreviated gestational period, the de-
gree of intrauterine growth restriction, or extrauterine growthnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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scope of this paper [42]. Although current guidelines recommend
aiming for a growth velocity approximating fetal growth prior to
term corrected age (CA) [5], disproportional but accelerated growth
in the ﬁrst months after birth may result in worse metabolic out-
comes later in life [39]. Some have recommended that preterm in-
fants without growth faltering at discharge receive maternal breast
milk or, a formula intended for term infants if breast milk is not
available [1,35]. When infants exhibit poor growth at discharge
additional nutrients and energymay better support growth; and for
these infants fortiﬁcation of breast milk or the use of nutrient
enriched formulae has been recommended [1,35]. However, recent
meta-analyses failed to show signiﬁcant beneﬁts from fortifying
breast milk as available studies are few [68] and inconsistent ben-
eﬁts of enriched formulae such as preterm or speciﬁc post-
discharge formulae [50] after discharge. Whilst meta-analyses are
considered to provide the highest level of evidence, there are sig-
niﬁcant challenges in applying their outcomes to practice situations.
This includes signiﬁcant heterogeneity in study design and
formulae composition, lack of homogeneity in patient population
and markedly different risk factors for poor nutritional status.
We adopted an ‘evidence mapping’ approach to address these
uncertainties. This emerging concept to assess clinical evidence is
reproducible and more inclusive than strictly focused meta-
analyses and provides insights into clearly-deﬁned but broad-
based topics by providing a comprehensive assessment of exist-
ing knowledge and its gaps [36]. Following the PICO strategy [24],
we identiﬁed variation in Participant population e Intervention e
Comparator e Outcomes of interventions where energy density
and/or nutrient ratio of formulae differed from the comparator. We
decided a priori to include all studies to the topic, but allow
assessment of relevance by illustrating heterogeneity in addition to
outcomes of these varying nutrient interventions on growth, body
composition, and neurodevelopmental outcome.
2. Methods
2.1. Method of literature search
We followed the Preferred Reporting Items For Systematic Re-
views And Meta-Analyses (PRISMA) guidance [49] and searched
PubMED/MEDLINE, Web of Science and Dialog databases between
1980-present without language restriction but limited to “human”
(Search strategy: “preterm infants” OR “premature infants” OR “low
birth-weight” OR “low birthweight” OR LBW OR “very low birth-
weight”OR “very lowbirthweight”ORVLBWOR(extremely lowbirth
weight) OR ELBWOR infant OR newbornOR neonat*) AND (nutrition
OR formula* OR “infant formula” OR milk OR “preterm formula” OR
growth OR “infant nutrition”OR fortif? OR supplement?) AND (post-
discharge OR postdischarge OR “hospital discharge”). These were
followed by hand searches on conference abstract databases from
2000 e 2012 and 2014 (www.pas-meetings.org (Abstract archive))
using search terms “Preterm þ post þ discharge” or
“premature þ post þ discharge” and “discharge”, respectively.
Recent reviews (from 2009 e present) or identiﬁed study publi-
cations were cross-checked for additional studies not found by
electronic searches and specialty journalswhichwere not included in
the searched databases. We searched for follow-up publications by
ﬁrst and last name (senior author) and corresponding authors of
identiﬁed studies in PubMED and conference abstract databases and
cross-referencedourﬁndingswith theCochrane reviewon “Nutrient-
enriched formula versus standard term formula for preterm infants
following discharge”, from now on referred to as Cochrane 2012 [69].
The search was ﬁrst executed in April 2013, and repeated in
October 2013 (2010 e present), January 2014 (February 2013 epresent) and December 2014 (January e present) using the same
search strategy and allowing for overlap to ensure recent publica-
tions were not overlooked.
2.2. Study eligibility
A priori, we decided to include all studies whose intervention
started at or extended into the post-discharge period, independent
of the criteria that were applied to decide the circumstance under
which a preterm infant (born < 37 complete weeks gestational age
(GA)) was ﬁt to be discharged from the hospital. Comparisons were
either with a term formula, or between formulae with differing
degrees of nutrient and/or energy enrichment. We applied no re-
strictions to formula composition, start, type, or duration of inter-
vention, preterm infant population characteristics, sample size,
methods of randomization, blinding, stratiﬁcation, potential group
bias, drop out, compliance or lack of follow-up. Studies were
limited to those with measurements of relevant outcome growth
parameters (weight, length, and HC), gains, z-scores or data related
to body composition assessment or cognitive function. In-
vestigations restricted to in-hospital interventions, mixed paren-
teral and enteral interventions or comparisons of formulae to
fortiﬁed breast milk, between preterm and term infants, or with
focus on bone parameters alone were excluded as were follow-up
publications of included studies not reporting growth, body
composition and/or neurodevelopment.
We chose the ﬁrst authors' last name and year of the ﬁrst
publication as identiﬁer for each study. Data was combined with
subsequent publications including conference proceedings if these
contained novel information. Otherwise, they were excluded.
2.3. Formula categories
Studies were grouped by energy density of test and comparator
formulae only, irrespective of terminology used in the original
publication. Infant formulae developed to meet term infant re-
quirements contain between 60 to 70 kcal/100 ml [27]. In most
studies, such standard term formula (STF) was used as comparator.
Test formulae with similar energy density than the comparator but
higher macro-/micro-nutrient concentrations were grouped in the
category “enriched” standard term formulae (STF-e). For studies
investigating effects of protein quantity or quality (e.g. whey vs
casein), the isocaloric formula with highest protein and nutrient
concentrations was considered “enriched”. Formulae with highest
energy density were grouped in the “Preterm formula” (PTF)
category in line with terminology for in-hospital formulae, deﬁned
here as containing 80 kcal/100 ml.
Formulae with intermediate energy densities between 70 to
79 kcal/100 ml were grouped in the “Post-discharge” (PDF) cate-
gory despite the name being somewhat misleading since these
formulae are also provided before discharge in some hospitals.
In addition to higher energy density or increased protein con-
centrations, the test formulae most often also contained higher
concentrations of lipids, carbohydrates, and selected minerals and/
or vitamins. When using the term “enriched”, we refer to these
energy and nutrient differences between test and comparator
formulae. Consequently, comparisons between isocaloric but
energy-dense formulae differing in nutrient concentrations were
also labeled “enriched” (PDF-e or PTF-e, respectively).
2.4. Data extraction and recalculation
We recalculated formula composition values to present con-
centrations per 100 kcal, converted nutrient units to IU, mg or mg,
where applicable, and calculated ratios of protein:energy and
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mean birth weight, mean gestational age, anthropometrics and
sample size was extracted from tables or text wherever possible
and if the data was incomplete or unavailable from publication or
authors, we used it from Cochrane 2012 [69]. In case of discrep-
ancies, we applied publication information or direct correspon-
dence with the author. When the data was presented as standard
error of themean, we calculated standard deviations [square root of
(sample size minus one) multiplied by SEM].
Observations of volume intake, on gender or on auxological
parameters, body composition and neurodevelopment were
extracted from tables, ﬁgures, or from the text. As the intention of
formula enrichments with energy, macro- and/or micronutrients
was countering growth faltering, study outcomes are marked as
(un)favorable in the overviews.
For a broad mapping of effects and understanding in howmany
studies favorable or unfavorable effects had been reported, we
combined absolute measures, z-scores, gains and velocity not only
as signiﬁcant outcomes but also identiﬁed non-signiﬁcant trends
that were either described as such in the publication or were
measures with statistical outcomes of p < 0.1. Effects on gains were
ascribed to the end of the observation period, i.e. weight gain
between term and three months CA is recorded at three months
assessment time. Final study outcomes were captured as reported
by original authors. In addition, we compiled observations at
assessment times not only of the total population but also
included those for subgroups (boys, SGA) whenever these were
observed.
Since interpretation of changes in body composition is compli-
cated by a lack of agreement on the parameters of greatest interest,
we decided to capture the original author's interpretation in the
course of the study. Most authorities agree that promotion of LM
accretion whilst avoiding excessive adiposity is an important goal
for preterm infants [5]. However, although often reported fat or
lean mass percent (LM% or FM%) may not be the most reliable
parameter to determine changes in body composition because it
requires adjustment for linear size (for example the fat mass (FM)
index) [15,16]. Despite these challenges we annotate the differences
in LM or FM using the symbols [þ/] where body compositional
changes had been assessed at study end.3. Results
3.1. Identiﬁcation and selection
The ﬁrst search in 2013 resulted in 1260 hits which were
screened for relevance. From these, 58 publications were identiﬁed
(26 full text, 32 conference proceedings). The subsequent searches
led to two further full-text publications. Searches on abstract da-
tabases and for author names resulted in identiﬁcation of six
additional conference proceedings. All were screened for eligibility
and combined when relating to the same study. Conference pro-
ceedings were excluded when a related full-text publication con-
tained the same information. The most recent search identiﬁed one
follow-up publication but no novel study.
In total, 31 eligible studies that investigated effects of a feeding
intervention in preterm infants after hospital discharge were
included, 17 of which allowed extraction of growth data in relation
to P:E ratio.3.2. Data compilation
Many studies reported outcomes in subsequent publications.
This section describes for which studies data was combined.Data for Vengi 1997 [63] and Agosti 1999 [2] were extracted
from a review [48] since the original publications could not be
retrieved. Data for Cooke 1998 [20] was combined from three
subsequent publications [18,19,21] and information from the au-
thors (NDE). Data for Lucas 1992 [46] was combined with growth
data from Bishop et al. 1993 [11] whereas their comparator formula
composition was extracted from a subsequent review [32]. Lucas
2001 [47] was combined with Onyeador et al. 2011 [51]; Cooper
1985 [23] with Cooper et al. 1989 [22]; Roggero 2012 [58] with
Gianni et al. 2014 [31] and data from the authors. Authors for Amesz
2010 [6] and Roggero 2011 [59] provided additional data. Pittaluga
2011 [56] was combined with a previously published conference
abstract [55] whereas preliminary data for Roggero 2012 [58], Lit-
manovitz 2007 [45], and Picaud 2008 [54] previously published as
conference abstracts, were excluded aswere follow-up publications
without reports of growth [62]. One study, only published as con-
ference proceeding, investigated visual preference development
(Fagan Test of Infant Intelligence) of 104 preterm infants (birth
weight 725 e 1390 g) fed enriched formula from discharge to two
months CA [65], However, due to lack of information on formula
composition, it was excluded although results are brieﬂy discussed
in the Neurodevelopment section. Studies that were only published
as conference proceedings are identiﬁed by the letter ‘A’ following
the year [7,8,60].
3.3. Studies grouped by formula energy density
Of the 31 included studies, eight investigated effects of isocaloric
but nutrient enriched STF (67 e 68 kcal/100 ml) [6,9,10,
14,22,23,29,60,66]; Thirteen studies investigated effects of energy-
nutrient enriched PDF (selection range 70 e 80 kcal/100 ml, in
fact all studies used energy densities between 72 and 75 kcal/
100 ml) [7,8,11,13,26,31,32,40,45e47,51,58,59,61,63,67], and six
studies investigated effects of PTF continued after hospital discharge
(selection range 80 e 90 kcal/100 ml) ([3,12,18e21,38,53,54], Fig. 1,
Supplementary Table 1). One observational prospective cohort
comparison [56] evaluated effectiveness of a national feeding pro-
gram for preterm infants [55,56] and three studies evaluated
enrichment of a single nutrient (group) such as either long-chain
poly-unsaturated fatty acids [2] or predominantly minerals [44,57]
in comparison to an isocaloric comparator. These were identiﬁed
in separate categories.
3.4. Heterogeneity of study population and design
The challenge in synthesizing data from multiple studies is
illustrated when study feeding, design and population character-
istics are considered (Fig. 1). Sixteen studies included infants with a
birthweight below 2500e1620 g, twelve studies thosewith a birth
weight1500 g, and only two studies1100 g (Agosti, 1999; Vegni,
1997) [2,63], although Carver 2001 [13] and Koo 2006 [40] stratiﬁed
birth weight groups into this weight category. Mean gestational age
ranged from 26 to 34.3 weeks and mean birth weights from 870 to
1990 g. Consequently, body weight at intervention start varied
highly (1220e 3210 g) withmost values in the range of 2.0e 2.5 kg.
Seven studies investigated small-for-gestational age (SGA)
populations only, deﬁned using differing criteria (Agosti, 2003;
Amesz, 2010; Atkinson, 2004A; Roggero, 2011; Roggero, 2012;
Taroni, 2009; Vegni, 1997) [3,6,7,58,59,61,63], but in other studies
10 e 45% of the study population was SGA (Chan, 1994; Jeon, 2011;
Lucas, 2001; Picaud, 2008; Pittaluga, 2011; Raupp, 1997)
[14,38,47,54,56,57]. One study included appropriate-for-gestational
age (AGA)male subjects only (Agosti, 1999) [2]. Gender effects were
reported in detail in six studies (Agosti, 2003; Amesz, 2010; Carver,
2001; Cooke, 1998; Lucas, 2001; Koo, 2006) [3,6,13,20,40,47].
Fig. 1. Setup of 31 studies investigating effects of nutrition after discharge by alphabetical order per formula category. Observation period, intervention start and end are shown in
months corrected age per study. When the comparator formula was started and provided as long as test formula, it is not speciﬁcally shown. Feeding prior to intervention is
indicated between weeks 32 to intervention start (PTF e black, non-reported feeding or breast milk, PTF or a mix thereof e light grey), type of intervention is indicated by pattern
and shades (STF-e e light grey, PDF e medium grey, PTF e black, feeding after intervention e white). The arrows at Brunton 1998 [12] and Lapillonne 2004 [44] indicate the
intervention start with use of in-hospital PTF was extended post-discharge and used as comparator. Assessment times are breaks in ﬂow and number of subjects at end of
observational period are shown at study end. Time of discharge is indicated when differing from intervention start. Litmanovitz 2007 [45] and Jeon 2011 [38] investigated duration
of exposure to enriched formula, Roggero 2012 [58] investigated effects of enriched diet on AGA and SGA populations, and Agosti 2003 [3] compared PDF with PTF. Abbreviations:
PTF Preterm Formulae (80 e 90 kcal/100 ml); STF-e (enriched) Standard Term Formulae (60 e 70 kcal/100 ml: in fact all 67 e 68 kcal/100 ml); PDF Post-discharge Formulae (70 e
80 kcal/100 ml; in fact all had an energy density of 72 e 75 kcal/100 ml).
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or other complicating factors at discharge were excluded with
exception of Bunton,1998 [12] who focused on infants with chronic
lung disease (bronchopulmonary dysplasia, BPD). The overall
population for which data is available therefore reﬂects relatively
healthy and clinically stable preterm infants.
Prior to the intervention, infants in 11 studies received a PTF
whereas in the remaining studies, feeding type before interven-
tion start was either not reported or infants received breast milk,
a PTF or a mix thereof. Interventions started in hospital sub-
stantially before discharge, at discharge, or after discharge when
term corrected age and/or a certain body weight was reached. To
illustrate the variation in study setup, one study continued use of
PTF from full enteral feeding (30 e 34 postconceptual age) into
the discharge period till term CA (Lapillonne, 2004) [44] whereas
others continued PTF or fortiﬁed HM until term CA before
intervention start up to either 6 or 4 months CA, respectively
(Amesz, 2010; Agost, 2003) [3,6], compared to Cooke 1998 [20]
whose subjects intervention began at 36 weeks postconceptual
age till 6 months CA (Fig. 1).
Overall, the intervention period varied from four weeks to 12
months, assessment times from biweekly to every three months,
observation period ended with intervention or subjects were
followed-up to 5 e 8 years. All factors of study variation we iden-
tiﬁed are summarized in Table 1. In addition, we compiled infor-
mation on study formulae illustrating the high heterogeneity
between interventions from energy density and protein concen-
tration, fat quality, mineral densities and vitamin variations
(Supplementary Table 2).
3.5. Broad evidence mapping of effects on weight, length, and head
circumference
An overview of (un)favorable effects (Fig. 2) shows the end
result reported for the study, but also trends and signiﬁcances at
assessment times that includes sub-populations. Most authors did
not ﬁnd differences in auxological parameters at study end. This is
particularly apparent in the STF-e category where a few trends onTable 1
Heterogeneity of study design e major variation factors identiﬁed from eviden
Design characteristics Key examples
Population inclusion criteria 1. Gestation or birth
2. Inclusion/exclusio
3. Previous nutrition
4. Presence/absence
5. Approach to inclu
6. Stratiﬁcation to b
7. Sample size
Interventions 8. Energy density of
9. Macronutrient co
10. Micronutrient an
11. Differences in co
Trial related procedures 12. Blinding, maskin
13. Sample size dete
Study timing 14. Continuation of
15. Deﬁnition of dis
Exposure to intervention 16. Continuation un
Outcome assessments 17. Frequency and d
period and follow
Outcome parameters 18. Formula intake m
19. Absolute measur
study assessmen
20. Body compositio
absorptiometry o
21. Deﬁnition of qua
22. Neurodevelopmethe full or sub-populations were observed most often a few weeks
before and after term CA, with exception of Wheeler 1996 [66].
When differences were observed at study end, they were most
often favorable for the enriched diet group (Fig. 2). Only two studies
report better growth in the comparator group (Koo, 2006; Pitta-
luga, 2011) [40,56]. Interestingly Pittaluga 2011 [56], ﬁrst found
higher weight and linear growth at term to six months CA that
turned to be lower at 12 months CA in the enriched diet cohort,
which received PTF/PDF till six months CA whereas the historic
comparator cohort received STF from discharge on (Fig. 1). This
indicates a fast early weight and length gain in the early months
that slows at 18 months CA that is accompanied by a better
metabolic proﬁle.
Most differences occurred within the ﬁrst six months (Fig. 2).
However, 15 of the 31 studies did not publish their observations
beyond this age so longer term effects (e.g. at one year) are uncer-
tain. Differences in HCmeasures, especially in the PDF/PTF category,
were often not seen at early assessment times but only from six
months CA on. One study ﬁrst observed a trend for smaller HC for
their SGA population at term in the PTF group which changed to a
larger HC at 12 months CA, indicating catch-up growth (Fig. 2, [3]).
3.6. Quality of growth
In eighteen studies, body composition was determined using
different techniques (Fig. 3): One study measured mid-arm
circumference (MAC), another bioelectrical impedance analysis
(BIA); ﬁve measured skinfold thickness (SFT) and although differ-
ences early in the study were found, none detected differences at
the end of the respective observation period. However, when dual-
energy x-ray absorptiometry (DXA) and air displacement plethys-
mography (ADP) were used, differences in fat and lean mass ac-
cretion were observed in the course of seven studies.
Amesz 2010 [6] reported increased LM and decreased FM ac-
cretion related to body size in subjects that received PTF till term CA
followed by a protein and nutrient-rich STF-e (protein:energy (P:E)
ratio 2.54, Supplementary Table 2) till six months CA without
affecting any of the growth parameters (Figs. 2 and 3).ce mapping.
weight eligibility criteria
n of small for gestational age
al exposures e breast milk, formula, a mix thereof
of key neonatal pathologies
sion and randomization of infants from multiple pregnancy
irth weight, gender and/or sub-populations
milk formula
mposition of formula
d vitamin content of formula
mparator formula
g and randomization processes
rmination
preterm formula, or change to test formula before, at, or after discharge
charge criteria (by weight and/or age)
til speciﬁc post-menstrual age or weight was attained
uration of outcome assessment during intervention
-up period after intervention
easured or reported
es vs gain deﬁned differently (i.e. g/day, g/kg/day, g/week, or between
t times) vs change in parameter centiles (standard deviation scores)
n techniques e.g. skinfold thickness, dual X-ray
r air-displacement plethysmography
lity of growth
nt e.g. different tools and ages of assessment
Fig. 2. Overview Growth parameters at the end and during the studies. Any effect of enriched formula on either absolute measures, gains, z-scores of weight, length, or head
circumference as reported by the original authors was captured in this overview and identiﬁed as unfavorable (orange), favorable (blue) or ‘not different’ (grey). Trends as reported
in text or as p < 0.1 are identiﬁed by lighter shade. A diagonal line indicates that assessments were made but not reported. A crossed out section indicates that a visit took place but
that this particular parameter was not assessed.
I.C. Teller et al. / Clinical Nutrition 35 (2016) 791e801796Roggero 2012 [58] achieved proportional increases of LM and
lower FM accretion after supplying PDF (P:E ratio 2.7) for six
months also without reporting effects on growth.
Although subjects in the Chilean cohort [56] were lighter and
shorter than their historic control peers that had not received PDF
or PTF for six months (P:E ratio 2.8 e 3.0), they accrued similar lean
mass percentages and were less fat.
Cooke 1998 [20] and Lapillonne 2004 [44] proportionally
increased LM and FM with their respective interventions of six
months PTF (P:E ratio 2.75) or a higher protein calcium-phosphorus
rich PTF-e (P:E ratio 2.72) that was provided till one month CA
using the same assessment method.
Only one study identiﬁed unfavorable body composition (Koo,
2006) [40]. In line with their observations on lighter, shorter sub-
jects with lower HC after one year of supplying PDF (P:E ratio 2.6),
they found less accretion of either LM or FM (Figs. 2 and 3).
3.7. Neurodevelopment
Neurodevelopmental outcomes up to 24 months or later were
assessed in ten studies either by the Neonatal Behavioral Assess-
ment Scale (NBAS), Grifﬁth Mental Developmental Scale (GMDS),
Bayley Scales of Infant Development (BSID) or the Fagan Test of
Infant Intelligence [65]. Two of these identiﬁed signiﬁcant beneﬁts
of enriched formula (Vegni, 1997) [63], and Werkman et al. [65],
and one further study described a beneﬁcial trend (Agosti, 1999)
[2]. Both Agosti 1999 [2] and Vegni 1997 [63] included infants born
1100 g and analyzed SGA infants separately.
Interestingly, the preliminary analysis of the 24 months follow-
up of Roggero, 2012 [58] identiﬁed improved cognitive measuresvia GMDS in the PDF group (Gianni et al., 2013) [30]. Unfortunately,
this effect was no longer present in the complete population [31].
No unfavorable effects were identiﬁed applying any of the enriched
formulae (Fig. 4).
3.8. Volume intake and P:E ratio
Twenty-one studies published data on volume intake (Fig. 5).
Eight of these found a higher intake for the less energy-dense
comparator formula. Ten of the thirteen studies that did not ﬁnd
any consistent difference were comparing isocaloric formulae,
suggesting that infants adjusted their volume intake based on en-
ergy intake.
In line with this observation, we calculated the P:E ratio of test
and comparator formulae (Supplementary Table 2) and plotted
these against absolute measures of weight, length and head
circumference at three, six, and 12 months CA (Fig. 6 and Supple-
mental Figures).
Although it should be noted that the studies do not allow a direct
comparison because of variation in study population and setting
(Table 1, Fig.1), all three growth parameters increasedwhen a higher
P:E ratio was provided. In particular, length and head circumference
at 12 months CA appear greater with a higher P:E ratio.
3.9. Gender
Fourteen studies reported gender effects (Fig. 5). Of these,
nine reported that males responded more sensitively to the
enriched diet whereas ﬁve found no difference between formula
groups. Two studies reported a higher quality of growth
Fig. 3. Overview Body Composition assessed by different methods. Left panel: Reported outcomes in the course of the study were identiﬁed by original author as unfavorable
(orange), favorable (blue) or ‘not different’ (grey). Trends as reported in text or as p < 0.1 are identiﬁed by lighter shade. Right panel: Outcome at study end. Symbols þ and 
indicate less and more accretion of the respective tissue mass; the symbol ± indicates no difference thereof. A diagonal line indicates that assessments were made but not reported.
A crossed out section indicates that a visit took place but that this parameter was not assessed.
I.C. Teller et al. / Clinical Nutrition 35 (2016) 791e801 797particularly for males (Cooke, 1998; Amesz, 2010) [6,20], that was
not observed in Roggero 2012 [58]. Agosti 2003 [3] found higher
GMDS scores in boys at 6 and 9 months CA.
3.10. Speciﬁc populations
Several studies analyzed data on SGA subjects but found vari-
able effects (Figs. 2, 3 and 4): Neither Taroni 2009 [61] nor Roggero
[59] or [58] reported differences in any of the auxological param-
eters for the SGA population. In Roggero 2012 [58] both AGA and
SGA populations in the PDF intervention group showed more LM
gain especially between three to six months CA. However, only for
the AGA group were these ﬁndings signiﬁcant. Atkinson 2004A [7]
found greater linear growth whereas Amesz 2010 [6] found weight
and length gain as well as a higher quality of growth (less FM ac-
cretion) in the SGA population. Vegni 1997 [63] signiﬁcantly
improved GMDS scores at two years, and Agosti 2003 [3] improved
GMDS scores at six months CA together with greater linear growth.
Only Brunton 1998 [12] investigated subjects with BPD and they
observed greater linear growth, less accretion of total and relativefat mass in parallel to increased accretion of total and relative lean
mass applying a PTF intervention enriched in protein and minerals
but not in energy (Figs. 2 and 3, Supplementary Table 2).
4. Discussion
This review highlights the marked heterogeneity between
studies examining effects of post-discharge formula intervention
following the PICO strategy of evidencemapping [24,36]. The lack of
similarities between studies (Table 1, Supplementary Table 2, and
Fig. 1) with regard to population characteristics, inclusion criteria,
formula composition, initiation and duration of intervention, and
several other potential confounders of later growth undermines ef-
forts of meta-analyses. In addition, many of these studies relate to
infants born more than 10 e 20 years ago, where antenatal steroid
use, perinatal mortality and nutritional care were very different. The
highvariations inpre- andpost-discharge interventionperiodsmake
identiﬁcation of the most sensitive window of plasticity for nutrient
enrichment difﬁcult. This variation is in part due to the arbitrary
nature of “post-discharge”: age and stage at which an infant is sent
Fig. 4. Overview Neurodevelopment assessed by different methods between four months up to three years. Favorable impact of enriched formulae (trend p < 0.1 or stated in the
text by original author) is indicated in blue; statistically signiﬁcant outcomes in the darker shade. Grey indicates no difference. A diagonal line indicates that assessments were made
but not reported. A crossed out section indicates that a visit took place but that this parameter was not assessed. Note: Bayley Scales of Infant Development II; DXA, Dual-energy X-
ray absorptiometry; FM, Fat mass; LM, Lean body or fat-free mass; NBAS test.
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illness severity. Not all studies shared in-hospital feeding practices,
which especially in case of older studies may have resulted in study
populations having been fed unfortiﬁed maternal milk and thoseFig. 5. Volume Intake observations and effect by gender are shown for comparator and
intervention formula per study as reported by the original authors or extracted from
text. Symbols indicate effects that are equal to (¼), above (>), or below (<) the inter-
vention formula or other gender.having received PTF, which may have affected the magnitude of af-
fects, especially if groups were not stratiﬁed to previous feeding.
Similarly, the variation in formulae composition limits conclusion
about the highest effect of rate limiting nutrients. Drawing clear
conclusions from such heterogenous data is difﬁcult. Despite these
predicaments, there appears to be an association between the pro-
tein and nutrient concentrations, when energy is secured, with
growth, particularly onHC, andbodycomposition,more so thanwith
a particular formula type itself (Fig. 6).
The beneﬁt of providing protein and energy at a ratio2.5 to 3.0
until 6 months corrected age on growth and quality of growth is
worthy of note (Figs. 2, 3 and 6), (Amesz, 2010; Cooke, 1998; Rog-
gero, 2012; Pittaluga, 2011) [6,20,56,58]. Linear growth seems to be
most responsive to an increased P:E ratio as higher absolute mea-
sures are apparent from three months onwards; weight and HC are
visibly affected at 12 months (Fig. 6). However, the 5 e 8 year
follow-up of Lucas 2001 [51] indicates that these or similar effects
may only be transitory.
Quality of growthmeasures has not been ﬁrmly established [43].
Accretion of less visceral fat mass, increased LM or FM deposition in
the extremities rather than the trunk may all be indicators of a
more favorable distribution (Amesz et al., 2010; Cooke et al., 2001;
Koo et al., 2006; Pittaluga et al., 2011) [6,17,40,56]. Interestingly, the
cohort study that reported lighter and shorter children in the en-
ergy and nutrient enriched group at one and two years of age also
observed these children to accumulate less FM, including trunk fat,
but similar LM. This was paralleled by lower fasting serum insulin
concentrations, which indicates a better metabolic proﬁle for the
cohort having received a P:E ratio of 2.8 e 3.0 for six months
[55,56]. Interestingly, the study of Koo 2006 [40] showed very
different results for growth and quality of growth parameters
Fig. 6. Absolute measures of weight, length, head circumference at 12 months CA were plotted against the protein:energy ratio of study formulae and comparators. STF formulae
are marked in white, STF-e in light grey, PDF/PDF-e in medium grey, and PTF/PTF-e in black. The circle circumference indicates study population size. Speciﬁc study population
characteristics are added in brackets i.e. AGA/SGA for Roggero 2012 [58] or the two conditions of 3 and 6 months intervention with the same PTF for Jeon 2011 [38]. The simple
regression line indicates increases for all three growth parameters when a higher P:E ratio was provided, especially at 12 months CA. Linear growth seems to be most sensitive to a
high P:E ratio. Data at three and six months is provided as Supplementary material.
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explanation for the ﬁndings in this study and the majority of the
other studies found quite consistent trends towards results in favor
of the postdischarge formulas. In addition, there are no possibilities
to further explore what could have been the reason for these very
different results in the study of Koo 2006 [40].
Head circumference is a marker for brain growth and develop-
ment and is correlated to later cognitive function [25,33,34,52], but
we only identiﬁed one study (in growth restricted very low birth
weight infants) that suggested a persisting beneﬁt at 24 months of
age from an enriched diet [63]. Developmental assessmentmethods used in most studies e.g. BSID, are not designed to be tests
of cognitive function, and neither are they sufﬁciently sensitive to
detect nutrient effects unless such effects are large. None of the
studies were sufﬁciently powered to detect a realistic difference in
a global measure of development. MRI based techniques may
indicate effects on the brain [37], as might the developing tech-
nique of tractography. In one study a measure of corticospinal tract
function (MagSTim) suggested beneﬁts for brain damaged preterm
and term children, although the study was terminated early
because of the signiﬁcantly increased head growth from enhanced
caloric and protein intake over one year [25].
I.C. Teller et al. / Clinical Nutrition 35 (2016) 791e801800It is possible that the window of plasticity to inﬂuence neuro-
cognitive outcomes is less sensitive to nutritional interventions as
proposed [31]. However, ﬁndings such as those of Dabydeen and
colleagues [25] indicate differently and suggest the importance of
the ﬁrst year. It is as likely that the lack of long-term effects
including on neurodevelopmental outcomes may be related to the
majority of data having been collected from relatively healthy and
stable preterm infants. Subjects with feeding difﬁculty and
comorbidities were generally excluded [31,41]. We observed that
certain populations such as boys, SGA, and those with BPD partic-
ularly beneﬁt from protein and nutrient enrichment with regard to
growth and its quality.
Determining which speciﬁc nutrient exerts effects is virtually
impossible as nutritional studies are very different from most
pharmaceutical studies: Nutrition may be considered a ‘package’
intervention although in some speciﬁc studies a single nutrient
(e.g. iodine [48], predominantly minerals [44], or docosahexanoic
acid [2,48]) may be key drivers of any effects observed when pro-
tein and energy requirements are met. It is likely that the ﬁrst
limiting nutrient will set the ceiling for outcomes: other nutrients
may be important in affecting the outcome (e.g. neuro-
development) but their effects will not be apparent if other nutri-
ents are also impacting on development.
Our evidence mapping identiﬁed several research gaps that
include (1) the deﬁnition of healthy growth in the post-discharge
period, the questions (2) the window of highest plasticity for
intervention, (3) how compromised preterm infants with comor-
bidities, feeding difﬁculties, and growth faltering at discharge are
affected by a high protein:energy and/or nutrient:energy ratio, (4)
which nutrients besides protein are particularly relevant for
healthy growth and neurodevelopment, and (5) which techniques,
approaches, and measures are sensitive enough to capture subtle
developmental improvements on neurocognitive function and
behavior by nutritional interventions.
Overall, this review highlights the marked heterogeneity of
studies examining effects of post-discharge formula. Despite these
variables, we found that preterm infants in the post-discharge
period are able to adjust their volume intake by caloric density
and that the provision of a high P:E ratio seems beneﬁcial especially
for certain sub-populations. A high P:E ratio (2.5 e 2.7) provided
for six months CA seems to support growth and quality thereof.
Considering the heterogeneity of available data it seems prudent to
carefully monitor proportional growth of length and weight
avoiding overfeeding once a steady growth velocity has been
achieved.
Sources of support
ICT and RvE are employees of Nutricia Research. Neither NDE
nor IJG received compensation for their contribution to this work.
Nutricia Research funded costs of open access publication and color
ﬁgures.
Statement of authorship
ICT, NDE, RVE designed the research which was conducted by
ICT in form of study identiﬁcation, data extraction, and ﬁgure
generation. ICT, IJG, and NDE analyzed the data. All authors
contributed equally to manuscript writing and take equal re-
sponsibility for ﬁnal content.
Conﬂict of interest
RvE and ICT are employees of Nutricia Research, Utrecht, The
Netherlands. NDE has previously conducted research with supportfrom manufacturers of infant formula including Nestec SA
(Switzerland), Wyeth UK and Nutricia UK but did not receive any
payment, support, or beneﬁt in kind for contribution to this
manuscript and has no ongoing personal, consultancy or ﬁnancial
relationships with Nutricia or other relevant commercial interest.
IJG has nothing to declare.Acknowledgments
We want to thank Radoslava Trifonova for online searches and
study identiﬁcation beyond the call of duty and Paul Vervuren for
generation of the detailed P:E ratio plots. Both are employees of
Nutricia Research, Utrecht, The Netherlands.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.clnu.2015.08.006.References
[1] Aggett PJ, Agostoni C, Axelsson I, De Curtis M, Goulet O, Hernell O, et al.
Feeding preterm infants after hospital discharge: a commentary by the
espghan committee on nutrition. J Pediatr Gastroenterol Nutr 2006;42(5):
596e603.
[2] Agosti 1999 “From: Marini, A., Vegni, C., Gangi, S., Benedetti, V., Agosti, M.,
(2003) inﬂuence of different types of post-discharge feeding on somatic
growth, cognitive development and their correlation in very low birthweight
preterm infants.” Acta Paediatr Suppl 91(441): 18e33.
[3] Agosti M, Vegni C, Calciolari G, Marini A, The Investigators of the G.S.G.. Post-
discharge nutrition of the very low-birthweight infant: interim results of the
multicentric gamma study. Acta Paediatr 2003;92(Suppl. 441):39e43.
[5] Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, et al.
Enteral nutrient supply for preterm infants: commentary from the european
society of paediatric gastroenterology, hepatology and nutrition committee on
nutrition. J Pediatr Gastroenterol Nutr 2010;50(1):85e91.
[6] Amesz EM, Schaafsma A, Cranendonk A, Lafeber HN. Optimal growth and
lower fat mass in preterm infants fed a protein-enriched postdischarge for-
mula. J Pediatr Gastroenterol Nutr 2010;50(2):200e7.
[7] Atkinson SA, Pacs B, Saigal S, Hussey T, Lee D. Nutrient-enriched discharge
formula compared to standard formula does not beneﬁt growth, bone mineral
accretion or trace element status in preterm small for gestational age (sga)
infants to one year corrected age: a rct. In: Pediatric Academic Sciences (PAS)
Annual meeting, San Francisco, 2004, May 1e4; 2004.
[8] Atkinson SA, Randall-Simpson J, Chang M, Paes B. Randomized trial of feeding
nutrient-enriched vs standard formula to premature infants during the ﬁrst
year of life. In: American Pediatric Society and The Society of Pediatric
Research Meeting, San Francisco, CA, USA, Pediatr Res.; 1999.
[9] Bernbaum JC, Sasanow SR, Churella HR, Daft A. Growth and metabolic
response of premature infants fed whey- or casein-dominant formulas after
hospital discharge. J Pediatr 1989;115(4):652e6.
[10] Bhatia J, Rassin DK. Feeding the premature infant after hospital discharge:
growth and biochemical responses. J Pediatr 1991;118(4 Pt 1):515e9.
[11] Bishop NJ, King FJ, Lucas A. Increased bone mineral content of preterm infants
fed with a nutrient enriched formula after discharge from hospital. Arch Dis
Child 1993;68(5):573e8.
[12] Brunton JA, Saigal S, Atkinson SA. Growth and body composition in infants
with bronchopulmonary dysplasia up to 3 months corrected age: a random-
ized trial of a high-energy nutrient-enriched formula fed after hospital
discharge. J Pediatr 1998;133(3):340e5.
[13] Carver JD, Wu PY, Hall RT, Ziegler EE, Sosa R, Jacobs J, et al. Growth of preterm
infants fed nutrient-enriched or term formula after hospital discharge. Pedi-
atrics 2001;107(4):683e9.
[14] Chan GM, Borschel MW, Jacobs JR. Effects of human milk or formula
feeding on the growth, behavior, and protein status of preterm infants
discharged from the newborn intensive care unit. Am J Clin Nutr
1994;60(5):710e6.
[15] Chomtho S, Wells JC, Williams JE, Davies PS, Lucas A, Fewtrell MS. Infant
growth and later body composition: evidence from the 4-component model.
Am J Clin Nutr 2008a;87(6):1776e84.
[16] Chomtho S, Wells JC, Williams JE, Lucas A, Fewtrell MS. Associations between
birth weight and later body composition: evidence from the 4-component
model. Am J Clin Nutr 2008b;88(4):1040e8.
[17] Cooke RJ. Postnatal growth and development in the preterm and small for
gestational age infant. Nestle Nutr Workshop Ser Pediatr Program 2010;65:
85e95. discussion 96e88.
I.C. Teller et al. / Clinical Nutrition 35 (2016) 791e801 801[18] Cooke RJ, Embleton ND, Grifﬁn IJ, Wells JC, Mccormick KP. Feeding preterm
infants after hospital discharge: growth and development at 18 months of
age. Pediatr Res 2001;49(5):719e22.
[19] Cooke RJ, Grifﬁn IJ, Mccormick K. Adiposity is not altered in preterm infants
fed with a nutrient-enriched formula after hospital discharge. Pediatr Res
2010;67(6):660e4.
[20] Cooke RJ, Grifﬁn IJ, Mccormick K, Wells JCK, Smith JS, Robinson SJ, et al.
Feeding preterm infants after hospital discharge: effect of dietary manipula-
tion on nutrient intake and growth. Pediatr Res 1998;43(3):355e60.
[21] Cooke RJ, Mccormick K, Grifﬁn IJ, Embleton N, Faulkner K, Wells JC, et al.
Feeding preterm infants after hospital discharge: effect of diet on body
composition. Pediatr Res 1999;46(4):461e4.
[22] Cooper P, Rothberg A, Davies V, Horn J, Vogelman L. Three-year growth and
developmental follow-up of very low birth weight infants fed own mother's
milk, a premature infant formula, or one of two standard formulas. J Pediatr
Gastroenterol Nutr 1989;8(3):348e54.
[23] Cooper PA, Rothberg AD. Feeding of very-low-birth-weight infants with
special formulaecontinued use beyond 2000 g and effects on growth to 1
year. S Afr Med J 1985;67(18):716e8.
[24] Da Costa Santos CM, De Mattos Pimenta CA, Nobre MR. The pico strategy for
the research question construction and evidence search. Rev Lat Am Enferm
2007;15(3):508e11.
[25] Dabydeen L, Thomas JE, Aston TJ, Hartley H, Sinha SK, Eyre JA. High-energy
and -protein diet increases brain and corticospinal tract growth in term
and preterm infants after perinatal brain injury. Pediatrics 2008;121(1):
148e56.
[26] De Curtis M, Pieltain C, Rigo J. Body composition in preterm infants fed
standard term or enriched formula after hospital discharge. Eur J Nutr
2002;41(4):177e82.
[27] Efsa, Agostoni C, Canani RB, Fairweather-Tait S, Heinonen M, Korhonen H,
et al., Panel on Dietetic Products, N., And Allergies (Nda). Scientiﬁc opinion on
the essential composition of infant and follow-on formulae. EFSA J
2014;12(7):3760.
[28] Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retarda-
tion: an inevitable consequence of current recommendations in preterm in-
fants? Pediatrics 2001;107(2):270e3.
[29] Friel JK, Andrews WL, Matthew JD, Mckim E, French S, Long DR. Improved
growth of very low birthweight infants. Nutr Res 1993;13(6):611e20.
[30] Gianni ML, Roggero P, Amato O, Liotto N, Taroni F, Piemontese P, et al. Effect of
high protein and energy intakes on neurodevelopmental outcome of very low
birth weight infants. In: Pediatric Academic Societies (PAS) Annual meeting,
Washington, D.C. USA; 2013.
[31] Gianni ML, Roggero P, Amato O, Picciolini O, Piemontese P, Liotto N, et al.
Randomized outcome trial of nutrient-enriched formula and neuro-
development outcome in preterm infants. BMC Pediatr 2014;14:74.
[32] Grifﬁn IJ. Postdischarge nutrition for high risk neonates. Clin Perinatol
2002;29(2):327e44.
[33] Hack M. Survival and neurodevelopmental outcomes of preterm infants.
J Pediatr Gastroenterol Nutr 2007;45(Suppl. 3):S141e2.
[34] Hack M, Costello DW. Trends in the rates of cerebral palsy associated with
neonatal intensive care of preterm children. Clin Obstet Gynecol 2008;51(4):
763e74.
[35] Haiden N, €Ogkj. The nutrition committee together with the neonatology task
force of the Austrian society of pediatrics and adolescent medicine (€ogkj)
[Ern€ahrung frühgeborener nach der entlassung (German)]. Nutrition of pre-
mature infants after discharge. A concensus paper Monatsschr Kinderheilkd
2012;160(5):491e8.
[36] Hetrick SE, Parker AG, Callahan P, Purcell R. Evidence mapping: illustrating an
emerging methodology to improve evidence-based practice in youth mental
health. J Eval Clin Pract 2010;16(6):1025e30.
[37] Isaacs EB. Neuroimaging, a new tool for investigating the effects of early
diet on cognitive and brain development. Front Hum Neurosci 2013;7:
445.
[38] Jeon GW, Jung YJ, Koh SY, Lee YK, Kim KA, Shin SM, et al. Preterm infants fed
nutrient-enriched formula until 6 months show improved growth and
development. Pediatr Int 2011;53(5):683e8.
[39] Kerkhof GF, Willemsen RH, Leunissen RW, Breukhoven PE, Hokken-
Koelega AC. Health proﬁle of young adults born preterm: negative effects of
rapid weight gain in early life. J Clin Endocrinol Metab 2012;97(12):
4498e506.
[40] Koo WW, Hockman EM. Posthospital discharge feeding for preterm infants:
effects of standard compared with enriched milk formula on growth, bone
mass, and body composition. Am J Clin Nutr 2006;84(6):1357e64.
[41] Lapillonne A. Feeding the preterm infant after discharge. In: Koletzko B,
Pointdexter B, Uauy R, editors. Nutritional care of preterm infants: scientiﬁc
basis and practical guidelinesvol. 110. Basel, Switzerland: Karger; 2014.
p. 264e77.
[42] Lapillonne A, Grifﬁn IJ. Feeding preterm infants today for later metabolic and
cardiovascular outcomes. J Pediatr 2013a;162(3 Suppl.):S7e16.
[43] Lapillonne A, O'connor DL, Wang D, Rigo J. Nutritional recommendations for
the late-preterm infant and the preterm infant after hospital discharge.
J Pediatr 2013b;162(3 Suppl.):S90e100.
[44] Lapillonne A, Salle BL, Glorieux FH, Claris O. Bone mineralization and growth
are enhanced in preterm infants fed an isocaloric, nutrient-enriched preterm
formula through term. Am J Clin Nutr 2004;80(6):1595e603.[45] Litmanovitz I, Eliakim A, Arnon S, Regev R, Bauer S, Shainkin-Kestenbaum R,
et al. Enriched post-discharge formula versus term formula for bone strength
in very low birth weight infants: a longitudinal pilot study. J Perinat Med
2007;35(5):431e5.
[46] Lucas A, Bishop NJ, King FJ, Cole TJ. Randomised trial of nutrition for preterm
infants after discharge. Arch Dis Child 1992;67(3):324e7.
[47] Lucas A, Fewtrell MS, Morley R, Singhal A, Abbott RA, Isaacs E, et al. Ran-
domized trial of nutrient-enriched formula versus standard formula for
postdischarge preterm infants. Pediatrics 2001;108(3):703e11.
[48] Marini A, Vegni C, Gangi S, Benedetti V, Agosti M. Inﬂuence of different types
of post-discharge feeding on somatic growth, cognitive development and
their correlation in very low birthweight preterm infants. Acta Paediatr Suppl
2003;91(441):18e33.
[49] Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items
for systematic reviews and meta-analyses: the prisma statement. PLoS Med
2009;6(7):e1000097.
[50] Morgan JA, Young L, Mccormick FM, Mcguire W. Promoting growth for pre-
term infants following hospital discharge. Arch Dis Child Fetal Neonatal Ed
2012;97(4):F295e8.
[51] Onyeador N, Kennedy K, Fewtrell M, Lanigan J, Lucas A, Singhal A. Post-
discharge formula in preterm infants: effects on later growth, blood pressure,
and body composition. European Scociety for Paediatric Gastroenterology,
Hepatology, and Nutirion (ESPGHAN) Annual Meeting, Sorrento, Iraly.
J Pediatr Gastroenterol Nutr 2011.
[52] Orchinik LJ, Taylor HG, Espy KA, Minich N, Klein N, Shefﬁeld T, et al. Cognitive
outcomes for extremely preterm/extremely low birth weight children in
kindergarten. J Int Neuropsychol Soc 2011;17(6):1067e79.
[53] Peng CC, Hsu CH, Kao HA, Hung HY, Chang JH. Feeding with premature or
infant formula in premature infants after discharge: comparison of growth
and nutrition status. Acta Paediatr Taiwan 2004;45(3):151e7.
[54] Picaud JC, Decullier E, Plan O, Pidoux O, Bin-Dorel S, Van Egroo LD, et al.
Growth and bone mineralization in preterm infants fed preterm formula or
standard term formula after discharge. J Pediatr 2008;153(5):616e21.
[55] Pittaluga E, Llanos AR, Vernal P, Vega S, Henrriquez M-T, Morgues M, et al.
Effectiveness of a national program to optimize growth and development of
preterm infants using nutrient enhanced formulas. In: Pediatric Academic
Societies (PAS) Annual meeting, Baltimore, Maryland, USA; 2009.
[56] Pittaluga E, Vernal P, Llanos A, Vega S, Henrriquez M-T, Morgues M, et al.
Beneﬁts of supplemented preterm formulas on insulin sensitivity and body
composition after discharge from the neonatal intensive care unit. J Pediatr
2011;159(6):926e32. e922.
[57] Raupp P, Poss G, Von Kries R, Schmidt E. Effect of a calcium and phosphorus-
enriched formula on bone mineralization and bone growth in preterm infants
after discharge from hospital. Ann Nutr Metab 1997;41(6):358e64.
[58] Roggero P, Gianni ML, Amato O, Liotto N, Morlacchi L, Orsi A, et al. Growth and
fat-free mass gain in preterm infants after discharge: a randomized controlled
trial. Pediatrics 2012;130(5):e1215e1221.
[59] Roggero P, Gianni ML, Liotto N, Taroni F, Morniroli D, Mosca F. Small for
gestational age preterm infants: nutritional strategies and quality of growth
after discharge. J Matern Fetal Neonatal Med 2011;24(Suppl. 1):144e6.
[60] Sasanow SR, Bernbaum J, Dagostino J, Churella H. Growth and protein status
of lbw infants after hospital discharge fed formulas differing in amounts of
protein or human milk (hm). FASEB 75th Annual Meeting, Atlanta, Georgia,
USA Faseb J 1991.
[61] Taroni E, Liotto N, Orsi A, Piemontese P, Amato O, Morlacchi L, et al. Qualita
della crescita post-dimissione in prematuri nati piccoli per eta gestazionale:
Studio esplorativo (italian) “quality of post-discharge growth in small for
gestational age preterm infants: an explorative study”. Pediatr Med Chir (Med
Surg Ped) 2009;31(3):121e5.
[62] Van De Lagemaat M, Rotteveel J, Muskiet FA, Schaafsma A, Lafeber HN. Post
term dietary-induced changes in dha and aa status relate to gains in weight,
length, and head circumference in preterm infants. Prostagl Leukot Essent Fat
Acids 2011;85(6):311e6.
[63] Vegni 1997 “From: Marini, A., Vegni, C., Gangi, S., Benedetti, V., Agosti, M.,
(2003) Inﬂuence of different types of post-discharge feeding on somatic
growth, cognitive development and their correlation in very low birthweight
preterm infants.” Acta Paediatr Suppl 91(441):18e33.
[65] Werkman SH, Carlson SE. The fagan test of infant intelligence (ftii) and visual-
attention during the ftii e term and preterm infants fed term or preterm
formula after hospital discharge. Pediatr Res 1994. Seattle, Washington, USA,
Pediatric Research.
[66] Wheeler RE, Hall RT. Feeding of premature infant formula after hospital
discharge of infants weighing less than 1800 grams at birth. J Perinatol
1996;16(2 Pt 1):111e6.
[67] Wu F, Cui QL, Tan XH, Zhang H, Gao PM, Huang RZ, et al. 出院后喂养方式对早
产低出生体重儿生后３个月生长指标增长率的影响 (chinese) [[Effects of feeding
patterns after hospital discharge on increase rates of growth indices in pre-
term and low-birth-weight infants within 3 months after birth]]. Zhongguo
Dang Dai Er Ke Za Zhi 2013;15(2):129e32.
[68] Young L, Embleton ND, Mccormick FM, Mcguire W. Multinutrient fortiﬁcation
of human breast milk for preterm infants following hospital discharge.
Cochrane Database Syst Rev 2013;2.
[69] Young L, Morgan J, Mccormick FM, Mcguire W. Nutrient-enriched formula
versus standard term formula for preterm infants following hospital
discharge. Cochrane Database Syst Rev 2012;3.
